Comment on "The role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease"
- PMID: 32166803
- DOI: 10.1002/mds.27977
Comment on "The role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease"
Comment in
-
Reply to: Comment on "the role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease".Mov Disord. 2020 Mar;35(3):521-522. doi: 10.1002/mds.27972. Mov Disord. 2020. PMID: 32166804 No abstract available.
Comment on
-
The role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease.Mov Disord. 2019 Sep;34(9):1243-1251. doi: 10.1002/mds.27779. Epub 2019 Jul 10. Mov Disord. 2019. PMID: 31291491 Review.
References
-
- Moosa S, Martinez-Fernandez R, Elias WJ, Del Alamo M, Eisenberg HM, Fishman PS. The role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease. Mov Disord 2019;34(9):1243-1251.
-
- Schlesinger I, Eran A, Sinai A, et al. MRI guided focused ultrasound thalamotomy for moderate-to-severe tremor in Parkinson's disease. Parkinson's Disease 2015;2015:219149.
-
- Magara A, Bühler R, Moser D, Kowalski M, Pourtehrani P, Jeanmonod D. First experience with MR-guided focused ultrasound in the treatment of Parkinson's disease. J Therc Ultrasound 2014;2(1):11.
-
- Ito H, Fukutake S, Yamamoto K, Yamaguchi T, Taira T, Kamei T. Magnetic resonance imaging-guided focused ultrasound thalamotomy for Parkinson's disease. Intern Med 2018;57(7):1027-1031.
-
- Narabayashi H, Yokochi F, Nakajima Y. Levodopa-induced dyskinesia and thalamotomy. J Neurol Neurosurg and Psychiatry 1984;47(8):831-839.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
